Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...

Cantargia (Cantargia AB); today announced new clinical results from two nadunolimab combination therapy trials in 54 patients. Positive signals of efficacy were documented in the key areas of ...

Research shows neuropathy can be more severe and more common in Black breast cancer patients, causing doctors to dial back ...

The Bcl-2 inhibitor venetoclax is highly effective and is another first- or second-line option even if this agent, like BTK inhibitors, also appears to require continuous dosing, said Stadtmauer, ...

A recent study by Dr. Jordan Verplank, Assistant Professor in the Department of Anatomy, Physiology, and Genetics at the ...

Dr Shiva Kumar R, head of the department and senior consultant in Neurology and Epileptology at Manipal Hospitals, Sarajapur ...

A mom of three young children, Craig resident Tanisha Young, 29, recently lost her dad, and in past times in her life, that ...

SPONSORED – Neuropathy is becoming a bigger problem for more people than ever before. If you`re suffering from stabbing pain, ...

AstraZeneca and Ionis are set fair for EU approval of Wainzua, their treatment for polyneuropathy associated with ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

Wainzua had been previously approved for use by patients with ATTRv-PN in the United States, under the brand name Wainua.